NonprofitsGlobal Alliance For Tb Drug Development Inc

Medical Research

Global Alliance For Tb Drug Development Inc

NEW YORK, NY

Total revenue

$63.7M

Total expenses

$61.5M

Net assets

$176.3M

Grants received

$74.5M

19 grants

EIN

134128413

Tax year

2024

Mission

To accelerate the discovery & development of new drugs to facilitate the control of tuberculosis throughout the world and the accessibility of these drugs to the global community.

Programs

2 programs

Public affairs and policy - tb alliance maintains critical alliances with public and private organizations to raise awareness about tuberculosis ("tb") and advocate for public and private involvement in research for the public good. Specifically, tb alliance negotiates terms that support the development and access of new affordable anti-tb drugs equitably for those areas most in need while encouraging the private sector on the development of these medicines. Tb alliance continues to pursue an explicit commitment to our "aaa mandate" - that all new products will be adopted, available and affordable to those with tb.

Expenses: $5.6MGrants: $360K

Business development - tb alliance negotiates, implements and manages agreements with public and private organizations worldwide and does so by adhering to sound business practices while ensuring the public good. Specifically, tb alliance negotiates terms that support the development and access of new affordable anti-tb drugs equitably to those areas most in need while encouraging the private sector to help develop new medicines for tb indications.

Expenses: $852K

Financials

FY 2024

Revenue

Contributions & grants$52.7M
Program service revenue
Investment income$9.7M
Other revenue$1.3M
Total revenue$63.7M

Expenses

Grants paid$360K
Salaries & benefits$18.0M
Fundraising$1.4M
Other expenses$43.2M
Total expenses$61.5M
Total assets$204.3M
Net assets$176.3M

People

23 listed

NameRoleCompensation

DR MELVIN SPIGELMAN

PRESIDENT/CEO

Board

$940K

45 hrs/wk

COLLEEN PERO

SECRETARY/CAO

Board

$470K

45 hrs/wk

ANGELA VANDERPLOEG

TREASURER/CFO

Board

$422K

45 hrs/wk

SUNDAR KODIYALAM

DIRECTOR

Board

3 hrs/wk

DAVID NORTON

CHAIR

Board

3 hrs/wk

AKSHAY VAISHNAW

DIRECTOR (AS OF 12/01/24)

Board

3 hrs/wk

ANN TAYLOR

DIRECTOR (AS OF 09/01/24)

Board

3 hrs/wk

ERIC GOOSBY

DIRECTOR

Board

3 hrs/wk

KIM SCHWARTZ

DIRECTOR

Board

3 hrs/wk

MITCHELL WARREN

DIRECTOR

Board

3 hrs/wk

RASHA HIBRI

DIRECTOR

Board

3 hrs/wk

RATAN WATAL

DIRECTOR

Board

3 hrs/wk

SRISHTI GUPTA

DIRECTOR (AS OF 12/01/24)

Board

3 hrs/wk

ARIEL PABLOS-MENDEZ

VICE-CHAIR

Board

3 hrs/wk

DR EUGENE SUN

SR. VP, RESEARCH & DEVELOPMENT

Staff

$581K

45 hrs/wk

DR NADER FOTOUHI

SR. VP, CHIEF SCIENTIFIC OFFICER

Staff

$565K

45 hrs/wk

MARIA BEUMONT

VP, CHIEF MEDICAL OFFICER

Staff

$498K

45 hrs/wk

ROBERT LORETTE

SR. VP, BUSINESS DEVELOPMENT

Staff

$449K

45 hrs/wk

KATHLEEN SCHOSTACK

SR. VP, PROGRAM & ALLIANCE MANAGEMENT

Staff

$432K

45 hrs/wk

SALAH FORAIDA

SR. DIRECTOR, MEDICAL AFFAIRS

Staff

$430K

45 hrs/wk

SANDEEP JUNEJA

SR. VP, MARKET ACCESS

Staff

$418K

45 hrs/wk

RAJNEESH TANEJA

VP, PHARMACEUTICAL PRODUCT DEVELOPMENT

Staff

$371K

45 hrs/wk

PIETRO O TURILLI

SR. VP, EXTERNAL AFFAIRS

Staff

$369K

45 hrs/wk

Independent contractors

PPD DEVELOPMENT LP

GLOBAL CRO

$4.3M

WUXI APPTEC (HONGKONG) LIMITED

INTEGRATED R&D SERVICES

$3.5M

CERBA RESEARCH NV

LAB COSTS

$2.8M

CLININVENT RESEARCH PVT LTD

DRUG MANUFACTURING / TESTING

$2.0M

GLAXOSMITHKLINE INVESTIGACION

EXTERNAL MINI PORTFOLIOS

$1.6M

Grants received

Showing 19 of 19

FromAmountPurposeYear
$14.9M
TUBERCULOSIS
2024
$400K
TUBERCULOSIS
2024
$150K
DEVELOPMENT OF SOLUTIONS TO IMPROVE GLOBAL HEALTH
2024
$12K
TO ASSIST THE ORGANIZATION IN CARRYING OUT ITS EXEMPT PURPOSE
2024
$14.9M
TUBERCULOSIS
2023
$1.8M
TUBERCULOSIS
2023
$10K
RESEARCH AND LEARNING OPPORTUNITIES
2023
$9K
TO ASSIST THE ORGANIZATION IN CARRYING OUT ITS EXEMPT PURPOSE
2023
$8K
FOR RECIPIENT'S EXEMPT PURPOSE
2023
$14.3M
TUBERCULOSIS
2022
$5.1M
TUBERCULOSIS
2022
$80K
DEVELOPMENT OF SOLUTIONS TO IMPROVE GLOBAL HEALTH
2022
$9K
TO ASSIST THE ORGANIZATION IN CARRYING OUT ITS EXEMPT PURPOSE
2022
$5K
RESEARCH AND LEARNING OPPORTUNITIES
2022
$21.1M
TUBERCULOSIS
2020
$19K
INTERNATIONAL
2020
$5K
RESEARCH AND LEARNING OPPORTUNITIES
2020
$1.5M
PUBLIC, SOCIETAL BENEFIT
2017
$8K
SUB-AWARD
2017

Funded by

$74.5M from 5 funders · 19 grants · 2017–2024

Gates Foundation

$72.9M · 12 grants · 2020–2024

National Philanthropic Trust

$1.5M · 2 grants · 2017–2020

Grace Jones Richardson Testamentary

$30K · 3 grants · 2022–2024

Johns Hopkins University

$8K · 1 grant · 2017

Details

EIN134128413
NTEE codeH80
Subsection03
Ruling date2000-09
Formed2000
Employees50
Volunteers11
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC — Mission, Financials & Grants Received | Grantivo